The TP53 gene, tobacco exposure, and lung cancer

Shinichi Toyooka, Toshihide Tsuda, Adi F. Gazdar

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

Of the various genetic alterations in lung cancer, the abnormalities of the TP53 gene (p53) are among the most frequent and important events. Because of its importance, many aspects of TP53 have been studied, including preneoplastic lesions and TP53 as a marker for early detection and prognosis and as a therapeutic option. We summarize recent knowledge of TP53 in lung cancer with a special emphasis on the relationship between smoking exposure (e.g, cigarette, etc.) and specific mutational pattern of TP53 by analyzing the latest version of the International Agency for Research on Cancer (IARC) database on TP53 mutations in human cancer. Our analysis confirmed several other studies showing significant differences in the frequencies of G:C to T:A transversions between ever-smokers and never-smokers. Furthermore, when comparing the mutational spectrum by gender, important differences were noted between male and female never-smokers. We concluded that the previously noted G:C to T:A transversions were mainly due to female smokers having a high frequency of these changes compared to female never-smokers. There was no relationship between adenocarcinomas and squamous cell carcinomas independent of gender. We also examined the seven codons which have been previously identified as hot spots, that is, the sites of frequent G:C to T:A transversions in smoking-related lung cancers. However, there was no specific codon which was strongly related to smoke exposure despite a moderate relationship. We considered the term "warmspot" may be more appropriate. While mutations of TP53 are frequent in lung cancers, further investigation is necessary to understand their role for lung carcinogenesis, especially as they relate to gender differences, and to translate our laboratory knowledge to clinical applications.

Original languageEnglish (US)
Pages (from-to)229-239
Number of pages11
JournalHuman Mutation
Volume21
Issue number3
DOIs
StatePublished - 2003

Fingerprint

p53 Genes
Tobacco
Lung Neoplasms
Codon
Smoking
International Agencies
Mutation
Smoke
Tobacco Products
Squamous Cell Carcinoma
Neoplasms
Carcinogenesis
Adenocarcinoma
Databases
Lung
Research
Therapeutics

Keywords

  • Cancer
  • Carcinogen
  • Exposure
  • Lung cancer
  • Mutgen
  • P53
  • Risk factor
  • Tobacco
  • TP53

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Toyooka, S., Tsuda, T., & Gazdar, A. F. (2003). The TP53 gene, tobacco exposure, and lung cancer. Human Mutation, 21(3), 229-239. https://doi.org/10.1002/humu.10177

The TP53 gene, tobacco exposure, and lung cancer. / Toyooka, Shinichi; Tsuda, Toshihide; Gazdar, Adi F.

In: Human Mutation, Vol. 21, No. 3, 2003, p. 229-239.

Research output: Contribution to journalArticle

Toyooka, S, Tsuda, T & Gazdar, AF 2003, 'The TP53 gene, tobacco exposure, and lung cancer', Human Mutation, vol. 21, no. 3, pp. 229-239. https://doi.org/10.1002/humu.10177
Toyooka, Shinichi ; Tsuda, Toshihide ; Gazdar, Adi F. / The TP53 gene, tobacco exposure, and lung cancer. In: Human Mutation. 2003 ; Vol. 21, No. 3. pp. 229-239.
@article{0953b87be47344ed90ca426e12dcd83f,
title = "The TP53 gene, tobacco exposure, and lung cancer",
abstract = "Of the various genetic alterations in lung cancer, the abnormalities of the TP53 gene (p53) are among the most frequent and important events. Because of its importance, many aspects of TP53 have been studied, including preneoplastic lesions and TP53 as a marker for early detection and prognosis and as a therapeutic option. We summarize recent knowledge of TP53 in lung cancer with a special emphasis on the relationship between smoking exposure (e.g, cigarette, etc.) and specific mutational pattern of TP53 by analyzing the latest version of the International Agency for Research on Cancer (IARC) database on TP53 mutations in human cancer. Our analysis confirmed several other studies showing significant differences in the frequencies of G:C to T:A transversions between ever-smokers and never-smokers. Furthermore, when comparing the mutational spectrum by gender, important differences were noted between male and female never-smokers. We concluded that the previously noted G:C to T:A transversions were mainly due to female smokers having a high frequency of these changes compared to female never-smokers. There was no relationship between adenocarcinomas and squamous cell carcinomas independent of gender. We also examined the seven codons which have been previously identified as hot spots, that is, the sites of frequent G:C to T:A transversions in smoking-related lung cancers. However, there was no specific codon which was strongly related to smoke exposure despite a moderate relationship. We considered the term {"}warmspot{"} may be more appropriate. While mutations of TP53 are frequent in lung cancers, further investigation is necessary to understand their role for lung carcinogenesis, especially as they relate to gender differences, and to translate our laboratory knowledge to clinical applications.",
keywords = "Cancer, Carcinogen, Exposure, Lung cancer, Mutgen, P53, Risk factor, Tobacco, TP53",
author = "Shinichi Toyooka and Toshihide Tsuda and Gazdar, {Adi F.}",
year = "2003",
doi = "10.1002/humu.10177",
language = "English (US)",
volume = "21",
pages = "229--239",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - The TP53 gene, tobacco exposure, and lung cancer

AU - Toyooka, Shinichi

AU - Tsuda, Toshihide

AU - Gazdar, Adi F.

PY - 2003

Y1 - 2003

N2 - Of the various genetic alterations in lung cancer, the abnormalities of the TP53 gene (p53) are among the most frequent and important events. Because of its importance, many aspects of TP53 have been studied, including preneoplastic lesions and TP53 as a marker for early detection and prognosis and as a therapeutic option. We summarize recent knowledge of TP53 in lung cancer with a special emphasis on the relationship between smoking exposure (e.g, cigarette, etc.) and specific mutational pattern of TP53 by analyzing the latest version of the International Agency for Research on Cancer (IARC) database on TP53 mutations in human cancer. Our analysis confirmed several other studies showing significant differences in the frequencies of G:C to T:A transversions between ever-smokers and never-smokers. Furthermore, when comparing the mutational spectrum by gender, important differences were noted between male and female never-smokers. We concluded that the previously noted G:C to T:A transversions were mainly due to female smokers having a high frequency of these changes compared to female never-smokers. There was no relationship between adenocarcinomas and squamous cell carcinomas independent of gender. We also examined the seven codons which have been previously identified as hot spots, that is, the sites of frequent G:C to T:A transversions in smoking-related lung cancers. However, there was no specific codon which was strongly related to smoke exposure despite a moderate relationship. We considered the term "warmspot" may be more appropriate. While mutations of TP53 are frequent in lung cancers, further investigation is necessary to understand their role for lung carcinogenesis, especially as they relate to gender differences, and to translate our laboratory knowledge to clinical applications.

AB - Of the various genetic alterations in lung cancer, the abnormalities of the TP53 gene (p53) are among the most frequent and important events. Because of its importance, many aspects of TP53 have been studied, including preneoplastic lesions and TP53 as a marker for early detection and prognosis and as a therapeutic option. We summarize recent knowledge of TP53 in lung cancer with a special emphasis on the relationship between smoking exposure (e.g, cigarette, etc.) and specific mutational pattern of TP53 by analyzing the latest version of the International Agency for Research on Cancer (IARC) database on TP53 mutations in human cancer. Our analysis confirmed several other studies showing significant differences in the frequencies of G:C to T:A transversions between ever-smokers and never-smokers. Furthermore, when comparing the mutational spectrum by gender, important differences were noted between male and female never-smokers. We concluded that the previously noted G:C to T:A transversions were mainly due to female smokers having a high frequency of these changes compared to female never-smokers. There was no relationship between adenocarcinomas and squamous cell carcinomas independent of gender. We also examined the seven codons which have been previously identified as hot spots, that is, the sites of frequent G:C to T:A transversions in smoking-related lung cancers. However, there was no specific codon which was strongly related to smoke exposure despite a moderate relationship. We considered the term "warmspot" may be more appropriate. While mutations of TP53 are frequent in lung cancers, further investigation is necessary to understand their role for lung carcinogenesis, especially as they relate to gender differences, and to translate our laboratory knowledge to clinical applications.

KW - Cancer

KW - Carcinogen

KW - Exposure

KW - Lung cancer

KW - Mutgen

KW - P53

KW - Risk factor

KW - Tobacco

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=0037220167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037220167&partnerID=8YFLogxK

U2 - 10.1002/humu.10177

DO - 10.1002/humu.10177

M3 - Article

C2 - 12619108

AN - SCOPUS:0037220167

VL - 21

SP - 229

EP - 239

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 3

ER -